https://www.marketscreener.com/quote/stock/NEXIMMUNE-INC-118850398/news/NexImmune-Completes-Dosing-of-First-Cohort-in-Phase-1-2-Clinical-Trial-of-NEXI-001-in-Relapsed-Acute-33689779/?utm_source=telegram&utm_medium=social&utm_campaign=share